HomeNewsBusinessChina saves the day for JSPL as it returns to black in Q1

China saves the day for JSPL as it returns to black in Q1

The raging anti-China sentiment notwithstanding, JSPL has latched on to the export opportunity in the country, and other markets like Europe, to post a record quarterly EBITDA

July 23, 2020 / 14:42 IST
Story continues below Advertisement

Even as there is a call to reduce dependence on Chinese products, Indian businesses are latching on to the opportunity that the market in China provides.

Steelmaker Jindal Steel and Power(JSPL) has not only done that, but also used its China play to return to black and record its best ever EBITDA, or earnings before interest, taxes, depreciation and amortisation, for a quarter.

Story continues below Advertisement

While all the steelmakers increased their exports to China in the first three months of the financial year, it is the Naveen Jindal-led steelmaker that has made the most of the opportunity.

In 'normal times', JSPL used to export about 6,000 tons a month. But, from April onwards, that number shot up by over 2,000 times.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show